Century Therapeutics (IPSC)
US Market

Century Therapeutics (IPSC) Stock Price & Analysis


IPSC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.81 - $14.00
Previous Close$3.17
Average Volume (3M)122.63K
Market Cap
Enterprise Value-$11.13M
Total Cash (Recent Filing)$251.47M
Total Debt (Recent Filing)$51.47M
Price to Earnings (P/E)-1.5
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.14
Shares Outstanding59,580,817
10 Day Avg. Volume91,014
30 Day Avg. Volume122,626
Standard Deviation0.15
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)110.16
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.90
Enterprise Value/Gross Profit-2.14
Enterprise Value/Ebitda0.10
Price Target Upside459.94% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Century Therapeutics’s price range in the past 12 months?
Century Therapeutics lowest stock price was $2.81 and its highest was $14.00 in the past 12 months.
    What is Century Therapeutics’s market cap?
    Currently, no data Available
    When is Century Therapeutics’s upcoming earnings report date?
    Century Therapeutics’s upcoming earnings report date is Aug 10, 2023 which is in 68 days.
      How were Century Therapeutics’s earnings last quarter?
      Century Therapeutics released its earnings results on May 11, 2023. The company reported -$0.53 earnings per share for the quarter, missing the consensus estimate of -$0.524 by -$0.006.
        Is Century Therapeutics overvalued?
        According to Wall Street analysts Century Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Century Therapeutics pay dividends?
          Century Therapeutics does not currently pay dividends.
          What is Century Therapeutics’s EPS estimate?
          Century Therapeutics’s EPS estimate is -$0.54.
            How many shares outstanding does Century Therapeutics have?
            Century Therapeutics has 59,580,820 shares outstanding.
              What happened to Century Therapeutics’s price movement after its last earnings report?
              Century Therapeutics reported an EPS of -$0.53 in its last earnings report, missing expectations of -$0.524. Following the earnings report the stock price went down -1.749%.
                Which hedge fund is a major shareholder of Century Therapeutics?
                Among the largest hedge funds holding Century Therapeutics’s share is Baker Bros Advisors LP. It holds Century Therapeutics’s shares valued at 4M.


                  Century Therapeutics Stock Smart Score

                  The Century Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Century Therapeutics

                  Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.


                  Top 5 ETFs holding IPSC

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  iShares Biotechnology ETF
                  Vanguard Health Care ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Schwab U.S. Broad Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold IPSC. The ETFs are listed according to market value of IPSC within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Tango Therapeutics
                  Bluebird Bio
                  Avidity Biosciences

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis